skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Base de dados/Biblioteca: Academic Search Premier (EB_SDU_P3) remover Base de dados/Biblioteca: ClinicalKey remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

Davies, C ; Godwin, J ; Gray, R ; Clarke, M ; Cutter, D ; Darby, S ; McGale, P ; Pan, H C ; Taylor, C ; Wang, Y C ; Dowsett, M ; Ingle, J ; Peto, R

The Lancet (British edition), 2011-08, Vol.378 (9793), p.771-784 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

Coleman, R ; Powles, T ; Paterson, A ; Gnant, M ; Anderson, S ; Diel, I ; Gralow, J ; von Minckwitz, G ; Moebus, V ; Bergh, J ; Pritchard, KI ; Bliss, J ; Cameron, D ; Evans, V ; Pan, H ; Peto, R ; Bradley, R ; Gray, R ; Bartsch, R ; Dubsky, P ; Fesl, C ; Fohler, H ; Greil, R ; Jakesz, R ; Lang, A ; Luschin-Ebengreuth, G ; Marth, C ; Mlineritsch, B ; Samonigg, H ; Singer, CF ; Steger, GG ; Stoger, H ; Olivotto, I ; Ragaz, J ; Christiansen, P ; Ejlertsen, B ; Ewertz, M ; Jensen, MB ; Moller, S ; Mouridsen, HT ; Eiermann, W ; Hilfrich, J ; Jonat, W ; Kaufmann, M ; Kreienberg, R ; Schumacher, M ; Blohmer, JU ; Costa, SD ; Eidtmann, H ; Gerber, B ; Jackisch, C ; Loibl, S ; Dafni, U ; Markopoulos, C ; Blomqvist, C ; Saarto, T ; Ahn, JH ; Jung, KH ; Perrone, F ; Bass, G ; Brown, A ; Bryant, J ; Costantino, J ; Dignam, J ; Fisher, B ; Geyer, C ; Mamounas, EP ; Paik, S ; Redmond, C ; Swain, S ; Wickerham, L ; Wolmark, N ; Perez, E ; Ingle, JN ; Suman, VJ ; Hadji, P ; A'Hern, R ; Dowsett, M ; Makris, A ; Parton, M ; Pennert, K ; Powles, TJ ; Smith, IE ; Yarnold, JR ; Clack, G ; Van Poznak, C ; Safra, T ; Bell, R ; Coleman, RE ; Dodwell, D ; Hinsley, S ; Marshall, HC ; Solomayer, E ; Fehm, T ; Lester, J ; Winter, MC ; Horsman, JM ; Aft, R ; Brufsky, AM ; Llombart, HA

The Lancet (British edition), 2015-10, Vol.386 (10001), p.1353-1361 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials

Peto, R ; Davies, C ; Godwin, J ; Gray, R ; Pan, H C ; Clarke, M ; Cutter, D ; Darby, S ; McGale, P ; Taylor, C ; Wang, Y C ; Bergh, J ; Di Leo, A ; Albain, K ; Swain, S ; Piccart, M ; Pritchard, K

The Lancet (British edition), 2012-02, Vol.379 (9814), p.432-444 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Changes in Water Mobility Measured by Diffusion MRI Predict Response of Metastatic Breast Cancer to Chemotherapy
Changes in Water Mobility Measured by Diffusion MRI Predict Response of Metastatic Breast Cancer to Chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Changes in Water Mobility Measured by Diffusion MRI Predict Response of Metastatic Breast Cancer to Chemotherapy

Theilmann, Rebecca J. ; Borders, Rebecca ; Trouard, Theodore P. ; Xia, Guowei ; Outwater, Eric ; Ranger-Moore, James ; Gillies, Robert J. ; Stopeck, Alison

Neoplasia (New York, N.Y.), 2004-11, Vol.6 (6), p.831-837 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Cescon, David W ; Nowecki, Zbigniew ; Gallardo, Carlos ; Holgado, Esther ; Iwata, Hiroji ; Masuda, Norikazu ; Otero, Marco Torregroza ; Loi, Sherene ; Guo, Zifang ; Gonzalo, Gomez Abuin ; Diego, Kaen ; Matias, Molina ; Stephen, Begbie ; Philip, Clingan ; Sherene, Loi ; Dhanusha, Sabanathan ; Donatienne, Taylor ; Domicio Carvalho, Lacerda ; Fernando Cezar Toniazzi, Lissa ; Felipe, Silva ; Joanne, Yu ; Alejandro, Acevedo ; Bohuslav, Melichar ; Katarina, Petrakova ; Jana, Prausova ; Erik, Jakobsen ; Jeanette, Jensen ; Soren, Linnet ; Tamas, Lorincz ; Herve, Bonnefoi ; Isabelle, Desmoulins ; Jens-Uwe, Blohmer ; Nadia, Harbeck ; Jens, Huober ; Christian, Kurbacher ; Sibylle, Loibl ; Tibor, Csoszi ; Zsuzsanna, Kahan ; Karoly, Mahr ; John, Crown ; Seamus, O'Reilly ; Takaaki, Fujii ; Hiroji, Iwata ; Hirofumi, Mukai ; Seigo, Nakamura ; Shoichiro, Ohtani ; Akihiko, Osaki ; Yasuaki, Sagara ; Masato, Takahashi ; Koichiro, Tsugawa ; Junichiro, Watanabe ; Yutaka, Yamamoto ; Teruo, Yamauchi ; Angel, Gomez Villanueva ; Alejandro, Juarez Ramiro ; Flavia, Morales-Vasquez ; David, Porter ; Ewa, Chmielowska ; Ewa, Nowakowska-Zajdel ; Zbigniew, Nowecki ; Barbara, Radecka ; Joanna, Streb ; Alexander, Arkhipov ; Natalia, Fadeeva ; Oleg, Lipatov ; Kwong Hwa, Park ; Yeon Hee, Park ; Begona, Bermejo de las Heras ; Javier, Cortes ; Luis, de la Cruz Merino ; Jose, Garcia Saenz ; Maria, Gion ; Mei-Ching, Liu ; Chiun-Sheng, Huang ; Cagatay, Arslan ; Irfan, Cicin ; Erhan, Gokmen ; Ozgur, Ozyilkan ; Sinan, Yavuz ; Janine, Graham ; Mark, Tuthill ; Christopher, Twelves ; Duncan, Wheatley ; Oleksii, Kolesnik ; Olena, Kolesnik ; Alla, Nasonova ; Olga, Ponomarova ; Dmytro, Trukhin ; Sibel, Blau ; Madhu, Chaudhry ; Scott, Cole ; William, Irvin ; Randa, Loutfi ; Janice, Lu ; Coral, Omene ; Timothy, Panella ; Michael, Schleider ; Robert, Siegel ; Michael, Simon ; Frances, Valdes-Albini

The Lancet (British edition), 2020-12, Vol.396 (10265), p.1817-1828 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials

Anon

The Lancet (British edition), 2015-10, Vol.386 (10001), p.1341-1352 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial
Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial

Cuzick, Jack ; Sestak, Ivana ; Forbes, John F ; Dowsett, Mitch ; Cawthorn, Simon ; Mansel, Robert E ; Loibl, Sibylle ; Bonanni, Bernardo ; Evans, D Gareth ; Howell, Anthony

The Lancet (British edition), 2020-01, Vol.395 (10218), p.117-122 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial

Robertson, John F R, Prof ; Bondarenko, Igor M, Prof ; Trishkina, Ekaterina, PhD ; Dvorkin, Mikhail, MD ; Panasci, Lawrence, Prof ; Manikhas, Alexey, MD ; Shparyk, Yaroslav, PhD ; Cardona-Huerta, Servando, PhD ; Cheung, Kwok-Leung, MD ; Philco-Salas, Manuel Jesus, MD ; Ruiz-Borrego, Manuel, MD ; Shao, Zhimin, Prof ; Noguchi, Shinzaburo, Prof ; Rowbottom, Jacqui, MSc ; Stuart, Mary, MD ; Grinsted, Lynda M, MSc ; Fazal, Mehdi, MD ; Ellis, Matthew J, Prof

The Lancet (British edition), 2016-12, Vol.388 (10063), p.2997-3005 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

Baselga, José, Dr ; Bradbury, Ian, PhD ; Eidtmann, Holger, MD ; Di Cosimo, Serena, MD ; de Azambuja, Evandro, MD ; Aura, Claudia, MD ; Gómez, Henry, MD ; Dinh, Phuong, MD ; Fauria, Karine, PhD ; Van Dooren, Veerle, MSc ; Aktan, Gursel, MD ; Goldhirsch, Aron, MD ; Chang, Tsai-Wang, MD ; Horváth, Zsolt, MD ; Coccia-Portugal, Maria, MD ; Domont, Julien, MD ; Tseng, Ling-Min, MD ; Kunz, Georg, MD ; Sohn, Joo Hyuk, MD ; Semiglazov, Vladimir, MD ; Lerzo, Guillermo, MD ; Palacova, Marketa, MD ; Probachai, Volodymyr, MD ; Pusztai, Lajos, DPhil ; Untch, Michael, PhD ; Gelber, Richard D, PhD ; Piccart-Gebhart, Martine, PhD

The Lancet (British edition), 2012-02, Vol.379 (9816), p.633-640 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial

Cameron, David, Prof ; Piccart-Gebhart, Martine J, PhD ; Gelber, Richard D, PhD ; Procter, Marion, PhD ; Goldhirsch, Aron, MD ; de Azambuja, Evandro, MD ; Castro, Gilberto, MD ; Untch, Michael, MD ; Smith, Ian, MD ; Gianni, Luca, MD ; Baselga, Jose, MD ; Al-Sakaff, Nedal, PhD ; Lauer, Sabine, PhD ; McFadden, Eleanor, MA ; Leyland-Jones, Brian, MBBS ; Bell, Richard, MBBS ; Dowsett, Mitch, PhD ; Jackisch, Christian, MD

The Lancet (British edition), 2017-03, Vol.389 (10075), p.1195-1205 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1980  (13)
  2. 1980Até1992  (59)
  3. 1993Até2002  (168)
  4. 2003Até2013  (169)
  5. Após 2013  (97)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (503)
  2. Japonês  (37)
  3. Russo  (3)
  4. Espanhol  (2)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.